Latest news
{{'2025-12-18T13:08:27Z' | dateFormatFilter}}
Novo Nordisk files for FDA approval of CagriSema, the first once-weekly combination of GLP‑1 and amylin analogues for weight management
{{'2025-12-12T13:57:33Z' | dateFormatFilter}}
Novo Nordisk A/S: More efficacious dose of Wegovy® recommended by the European Medicines Agency can help people with obesity achieve an average of 20.7% weight loss
{{'2025-12-09T13:51:34Z' | dateFormatFilter}}
Novo Nordisk has completed its acquisition of Akero Therapeutics
Investors
Share price
{{priceData.date}} {{priceData.time}}
{{priceData.currentPrice}}
{{priceData.currency}}
Go to stock watch
{{priceData.change}} {{priceData.currency}}
